期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 105, 期 37, 页码 14052-14057出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0805902105
关键词
plasma amyloid beta40 and beta42; protofibrillar Abeta
资金
- National Institutes of Health [PO1-AG07232, P50-AG08702]
Plasma A beta 42 and A beta 40 levels are putative biomarkers for Alzheimer's disease (AD), but their significance and predictive value have been inconclusive. In AD transgenic models, plasma and cerebrospinal fluid levels of A beta 42 and A beta 40 increase with age but subsequently decrease when A beta begins to accumulate in brain and with the onset of cognitive impairment. To determine the predictive value of A beta levels in elderly populations, we investigated how plasma A beta 42, A beta 40, and a protofibrillar subspecies of A beta 42 changed over time and with the onset of cognitive impairment or AD. In a cohort of 1,125 elderly persons without dementia, 104 (9.2%) of the participants developed AD over 4.6 years of follow-up. Higher plasma A beta 42 levels at the onset of the study were associated with a threefold increased risk of AD. However, conversion to AD was accompanied by a significant decline in plasma A beta 42, a decreased A beta 42/A beta 40 ratio and, with the onset of cognitive impairment, decreased protofibrillar A beta 42 levels. Our results suggest individuals with elevated plasma A beta 42 are at increased risk of AD and that with the onset of disease, the decline in some forms of A beta may reflect compartmentalization of A beta peptides in the brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据